US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiora Pharmaceuticals

3.08

-0.0100-0.32%

Post-market: 3.07-0.0100-0.32%19:57 EDT

Volume:231.86K

Turnover:698.91K

Market Cap:9.38M

PE:-1.07

High:3.21

Open:3.04

Low:2.78

Close:3.09

Loading ...

Overview Company News Filings

Kiora Pharmaceuticals Inc. Concluded Annual Stockholders Meeting

Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating

Top Midday Gainers

MT Newswires Live

BRIEF-Kiora Pharmaceuticals - Enters Exclusive Option Agreement With Senju - SEC Filing

Kiora Pharmaceuticals Inc - Total Deal Value About $110 Mln Plus Royalties

THOMSON REUTERS

Kiora Pharmaceuticals Inc - Senju to Pay Kiora $1.25 Mln Immediate Option Payment - SEC Filing

THOMSON REUTERS

Kiora Pharmaceuticals Grants Senju Exclusive Option for KIO-301 Ophthalmic Treatment in Asia

Kiora Pharmaceuticals Reports Q1 2025 Financial Results

Kiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating

Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Kiora Pharmaceuticals Inc expected to post a loss of 67 cents a share - Earnings Preview

Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy

Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference

Kiora Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Kiora Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027

Kiora Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview

Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its Anti-Inflammatory Compound KIO-104

Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KPRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KPRX\",,,,,undefined,":{"symbol":"KPRX","market":"US","secType":"STK","nameCN":"Kiora Pharmaceuticals","latestPrice":3.08,"timestamp":1749240000000,"preClose":3.09,"halted":0,"volume":231864,"hourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.08,"latestTime":"19:57 EDT","volume":9401,"amount":28941.4891,"timestamp":1749254244178},"delay":0,"floatShares":2074257,"shares":3043857,"eps":-2.869259,"marketStatus":"Market Closed","change":-0.01,"latestTime":"06-06 16:00:00 EDT","open":3.04,"high":3.21,"low":2.78,"amount":698906.0785248,"amplitude":0.139159,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.869259,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1438315200000,"exchange":"NASDAQ","adjPreClose":3.09,"preHourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":3.09,"latestTime":"09:14 EDT","volume":3003,"amount":9407.0197221,"timestamp":1749215668754},"postHourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.08,"latestTime":"19:57 EDT","volume":9401,"amount":28941.4891,"timestamp":1749254244178},"volumeRatio":0.045066395498700576},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KPRX\",,,,,undefined,":{"symbol":"KPRX","floatShares":2074257,"roa":"-15.83%","roe":"-41.13%","lyrEps":0.928237,"volumeRatio":0.045066395498700576,"shares":3043857,"dividePrice":0,"high":3.21,"amplitude":0.139159,"preClose":3.09,"low":2.78,"week52Low":2.51,"pbRate":"0.40","psRate":"468.75","week52High":5.55,"institutionHeld":0,"latestPrice":3.08,"eps":-2.869259,"divideRate":0,"volume":231864,"delay":0,"ttmEps":-2.869259,"open":3.04,"prevYearClose":3.3,"prevWeekClose":2.98,"prevMonthClose":2.98,"prevQuarterClose":3.01,"fiveDayClose":2.98,"twentyDayClose":3.12,"sixtyDayClose":3.26},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KPRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541093002","title":"Kiora Pharmaceuticals Inc. Concluded Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541093002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541093002?lang=en_us&edition=fundamental","pubTime":"2025-06-05 02:34","pubTimestamp":1749062094,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc. held its Annual Meeting on June 4, 2025. During the meeting, stockholders voted on several proposals. Carmine Stengone and Brian M. Strem, Ph.D. were elected as Class I Directors. The appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. All proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiora Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLbNzNcB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX","BK4007"],"gpt_icon":0},{"id":"2541098847","title":"Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2541098847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541098847?lang=en_us&edition=fundamental","pubTime":"2025-06-05 00:15","pubTimestamp":1749053722,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Michael Okunewitch maintained a Buy rating on Kiora Pharmaceuticals (KPRX – Research Report) yesterday and set a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kiora-pharmaceuticals-strategic-partnerships-and-promising-financial-prospects-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kiora-pharmaceuticals-strategic-partnerships-and-promising-financial-prospects-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KPRX"],"gpt_icon":0},{"id":"2540060797","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2540060797","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540060797?lang=en_us&edition=fundamental","pubTime":"2025-06-04 01:37","pubTimestamp":1748972267,"startTime":"0","endTime":"0","summary":"ReShape Lifesciences (RSLS) said Tuesday that its Quality Management System and entire commercial portfolio of medical devices sold in Europe and the United Kingdom have been certified under the Europ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU1430594728.SGD","RSLS","KPRX","LU1585245621.USD","DG","BK4588","BK4155","BK4082","BK4585","BK4007","LU1989763690.USD","BK4114","LU1989763427.SGD"],"gpt_icon":0},{"id":"2540184779","title":"BRIEF-Kiora Pharmaceuticals - Enters Exclusive Option Agreement With Senju - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540184779","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540184779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:01","pubTimestamp":1748952105,"startTime":"0","endTime":"0","summary":"BRIEF-Kiora Pharmaceuticals - Enters Exclusive Option Agreement With Senju - SEC FilingJune 3  - Kiora Pharmaceuticals Inc KPRX.O:KIORA PHARMACEUTICALS INC - ENTERS EXCLUSIVE OPTION AGREEMENT WITH SENJU - SEC FILINGKIORA PHARMACEUTICALS INC - SENJU TO PAY KIORA $1.25 MILLION IMMEDIATE OPTION PAYMENT - SEC FILINGKIORA PHARMACEUTICALS INC - TOTAL DEAL VALUE ABOUT $110 MILLION PLUS ROYALTIESSource text: [ID:n0001372514-25-000050]Further company coverage: KPRX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S6061:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX","BK4007"],"gpt_icon":1},{"id":"2540751487","title":"Kiora Pharmaceuticals Inc - Total Deal Value About $110 Mln Plus Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2540751487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540751487?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:03","pubTimestamp":1748948581,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S6061:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KPRX","BK4007"],"gpt_icon":0},{"id":"2540147775","title":"Kiora Pharmaceuticals Inc - Senju to Pay Kiora $1.25 Mln Immediate Option Payment - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540147775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540147775?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:03","pubTimestamp":1748948581,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S6061:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KPRX","BK4007"],"gpt_icon":0},{"id":"2540775948","title":"Kiora Pharmaceuticals Grants Senju Exclusive Option for KIO-301 Ophthalmic Treatment in Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775948","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775948?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:01","pubTimestamp":1748948488,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc. has announced a strategic partnership with Senju Pharmaceutical Co., Ltd. granting Senju an exclusive option for the development and commercialization of KIO-301, aimed at treating ophthalmic diseases, across key Asian markets including Japan and China. The total potential deal value is estimated to be $110 million, in addition to tiered royalties on sales. Kiora is set to receive an immediate $1.25 million fee for this exclusive option, and should Senju exercise the option, Kiora will obtain a further mid-single digit million up-front payment along with development, regulatory, and commercial milestones. This agreement strengthens Kiora's global commercial reach, complementing their ongoing partnership with Théa outside of Asia, and highlights the demand for innovative treatments for retinal conditions such as retinitis pigmentosa.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL45lsGr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KPRX"],"gpt_icon":0},{"id":"2539202489","title":"Kiora Pharmaceuticals Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2539202489","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539202489?lang=en_us&edition=fundamental","pubTime":"2025-05-31 11:54","pubTimestamp":1748663695,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals, Inc. ( ($KPRX) ) has released its Q1 earnings. Here is a breakdown of the information Kiora Pharmaceuticals, Inc. presented ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kiora-pharmaceuticals-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kiora-pharmaceuticals-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KPRX","BK4007"],"gpt_icon":0},{"id":"2534422070","title":"Kiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2534422070","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534422070?lang=en_us&edition=fundamental","pubTime":"2025-05-11 02:25","pubTimestamp":1746901510,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals (KPRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Ok...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kiora-pharmaceuticals-strong-financial-position-and-strategic-partnerships-propel-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kiora-pharmaceuticals-strong-financial-position-and-strategic-partnerships-propel-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KPRX"],"gpt_icon":0},{"id":"2534484918","title":"Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2534484918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534484918?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:01","pubTimestamp":1746795664,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryKiora Pharmaceuticals Inc KPRX.OQ reported a quarterly adjusted loss of 52 cents per share for the quarter en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH1P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2533463107","title":"Kiora Pharmaceuticals Inc  expected to post a loss of 67 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533463107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533463107?lang=en_us&edition=fundamental","pubTime":"2025-05-06 21:34","pubTimestamp":1746538445,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc  expected to post a loss of67cents a share - Earnings Preview Kiora Pharmaceuticals Inc KPRX.OQ KPRX.O is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL8N3RE1U6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2533585007","title":"Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2533585007","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533585007?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442800,"startTime":"0","endTime":"0","summary":"Encinitas, California-- - Kiora Pharmaceuticals, Inc. ,  today announced the results from a preclinical study demonstrating KIO-104 significantly reduced scar formation in an established in vivo model of proliferative vitreoretinopathy . The findings further support KIO-104 as a promising therapeutic candidate for inflammatory and proliferative diseases of the retina that lead to vision threatening scarring. The presentation, titled, \"KIO-104, a novel small molecule inhibitor of DHODH, effectively prevents proliferative vitreoretinopathy in a rabbit model,\" was presented by Romana Seda-Zehetner, MSc MScTox, Kiora's Director, Preclinical Development at the 2025 Association for Research in Vision and Ophthalmology  meeting.The high dose group (n=6) exhibited complete prevention of scar formation in all rabbits.Retinal detachments were induced in Dutch Belted rabbits  by subretinal injection of ~500 L of 0.25% hyaluronic acid into the right eye, inferior to the optic disc/medullary ray fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-presents-vivo-preclinical-110000616.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-presents-vivo-preclinical-110000616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KIO","KPRX"],"gpt_icon":0},{"id":"2524208007","title":"Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208007","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208007?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:00","pubTimestamp":1743764400,"startTime":"0","endTime":"0","summary":"Ecinitas, California-- - Kiora Pharmaceuticals  invites investors to view the Company's online presentation at the 24th Annual Needham Virtual Healthcare Conference on Thursday, April 10th, 2025, at 2:15 pm EDT.President & CEO, Brian M. Strem, Ph.D., will provide an update on the progress of the Company's pipeline and its planned Phase 2 clinical trials of KIO-104 for the treatment of retinal inflammation and of KIO-301 for the treatment of retinitis pigmentosa.Kiora Pharmaceuticals is a clinical-stage biotechnology company developing advanced therapies for retinal disease. We target critical pathways underlying retinal diseases using innovative small molecules to slow, stop, or restore vision loss. KIO-301 is being developed for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-present-24th-annual-110000954.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-present-24th-annual-110000954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","KPRX","HCSG","BK4007"],"gpt_icon":0},{"id":"2522852160","title":"Kiora Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522852160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522852160?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:42","pubTimestamp":1743158520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 06:42 ET (10:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2522021626","title":"Kiora Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021626","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021626?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:44","pubTimestamp":1742903092,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryKiora Pharmaceuticals Inc KPRX.OQ reported a quarterly adjusted loss of $1.04 per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q80SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2522005824","title":"Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522005824","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522005824?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:00","pubTimestamp":1742900400,"startTime":"0","endTime":"0","summary":"Encinitas, California-- - Kiora Pharmaceuticals, Inc.   today announced its 2024 financial results and provided an update on its pipeline of therapeutics for the treatment of retinal diseases.Key fourth quarter and 2025 year-to-date corporate highlights include:. Received approval to initiate ABACUS-2, a Phase 2 study of KIO-301 in retinitis pigmentosa  in collaboration with Théa Open Innovation .\"Following interactions with the FDA and European regulators, retinal specialists, and patient advocacy groups, it's clear that demonstrating improvement in functional vision is essential for marketing authorization as well as reimbursement. This underscores the importance of the investment in time that we are making to refine the clinical endpoints that can measure clinically meaningful improvement in patients with no vision or bare light perception. This will increase our confidence in the data we generate from ABACUS-2 as this same endpoint would likely serve as the primary endpoint for a P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-reports-2024-results-110000740.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-reports-2024-results-110000740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KPRX","BK4007"],"gpt_icon":0},{"id":"2521286058","title":"Kiora Pharmaceuticals Inc  expected to post a loss of 55 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521286058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521286058?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:54","pubTimestamp":1742561644,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc  expected to post a loss of55cents a share - Earnings Preview Kiora Pharmaceuticals Inc KPRX.OQ KPRX.O is expected to show a rise in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q413Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2511549333","title":"Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its Anti-Inflammatory Compound KIO-104","url":"https://stock-news.laohu8.com/highlight/detail?id=2511549333","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511549333?lang=en_us&edition=fundamental","pubTime":"2025-02-13 20:00","pubTimestamp":1739448000,"startTime":"0","endTime":"0","summary":"Encinitas, California-- - Kiora Pharmaceuticals, Inc.  today announced that the U.S. Patent and Trademark Office has issued a composition-of-matter patent  on a specific crystalline form, or polymorph, of KIO-104. KIO-104 is a novel, non-steroidal anti-inflammatory, small molecule inhibitor of dihydroorotate dehydrogenase . A Phase 2 clinical trial of KIO-104 for the treatment of retinal inflammation is expected to begin in the first half of 2025. This new patent is expected to extend protection of KIO-104 into 2043.This newly issued patent, titled, Polymorphs of a Dihydroorotate Dehydrogenase  Inhibitor, provides important and expanded intellectual property protection for KIO-104, specifically covering a critical and unique polymorph. This distinct crystalline form covered by the patent offers enhanced molecular stability and solubility, which are critical to optimize the manufacturing of the drug substance.\"Securing this patent issuance further extends and strengthens our existing IP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-secures-u-composition-120000613.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-secures-u-composition-120000613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KPRX","KIO","BK4007"],"gpt_icon":0},{"id":"2510800551","title":"Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800551","media":"Newsfile","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800551?lang=en_us&edition=fundamental","pubTime":"2025-02-11 19:45","pubTimestamp":1739274300,"startTime":"0","endTime":"0","summary":"KLARITY is a multi-center, open label study in up to 28 patients. The primary objective is to evaluate safety and tolerability of repeated doses of KIO-104 administered by standard intravitreal injection. Secondary endpoints will evaluate the magnitude of macula edema reduction, improvement in visual acuity and the systemic pharmacokinetic profile of KIO-104. The study will enroll patients with macular edema secondary to one of the following diseases: diabetic retinopathy, non-infectious uveitis, retinal vein occlusion, or post pseudophakic cataract surgery. The study will be performed in two parts as follows:. Part A  will assess the safety and efficacy of three injections administered once every two weeks in 8 subjects. Cohort 1 of will receive 3.5 μg doses of KIO-104 while Cohort 2 will receive 10 μg doses of KIO-104.KIO-104 works by suppressing T cell numbers and function in the eye responsible for driving inflammation. Specifically, KIO-104 inhibits the mitochondrial enzyme, DHODH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kiora-receives-approval-initiate-klarity-114500418.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiora-receives-approval-initiate-klarity-114500418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KIO","BK4007","KPRX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KPRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"KPRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-03-25","symbol":"KPRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.74,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2024-11-08","symbol":"KPRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2024-08-09","symbol":"KPRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-06-11","symbol":"KPRX","defaultRemindTime":1718112600000,"type":"split","dateTimestamp":1718078400000,"forFactor":9,"toFactor":1,"ratio":9}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KPRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1716264000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KPRX","date":"2025-06-06","current":-0.780447,"percent":0.435313,"low":-6.455291,"twenty":-2.351675,"median":-0.470125,"eighty":-0.226277,"high":5.670624,"avg":-0.737585,"sd":2.263885,"marketCap":9405518},"quantilePoints":[{"date":"2020-06-12","current":-2.444026,"twenty":-2.406712,"median":-1.710666,"eighty":-1.28444,"marketCap":24244012},{"date":"2020-06-19","current":-2.346078,"twenty":-2.406712,"median":-1.719851,"eighty":-1.285691,"marketCap":23272401},{"date":"2020-06-26","current":-2.355406,"twenty":-2.402048,"median":-1.725313,"eighty":-1.286849,"marketCap":23364936},{"date":"2020-07-02","current":-2.215481,"twenty":-2.383391,"median":-1.735062,"eighty":-1.287775,"marketCap":21976920},{"date":"2020-07-10","current":-2.322757,"twenty":-2.383391,"median":-1.741666,"eighty":-1.288877,"marketCap":23041065},{"date":"2020-07-17","current":-2.364735,"twenty":-2.402981,"median":-1.746654,"eighty":-1.29027,"marketCap":23457470},{"date":"2020-07-24","current":-2.215481,"twenty":-2.383391,"median":-1.750379,"eighty":-1.293869,"marketCap":21976920},{"date":"2020-07-31","current":-1.902982,"twenty":-2.378727,"median":-1.753426,"eighty":-1.299074,"marketCap":18877017},{"date":"2020-08-07","current":-1.964089,"twenty":-2.378727,"median":-1.758939,"eighty":-1.302486,"marketCap":19247155},{"date":"2020-08-14","current":-2.431504,"twenty":-2.383391,"median":-1.760939,"eighty":-1.306716,"marketCap":23827608},{"date":"2020-08-21","current":-2.190714,"twenty":-2.378727,"median":-1.767229,"eighty":-1.308271,"marketCap":21467980},{"date":"2020-08-28","current":-1.940482,"twenty":-2.378727,"median":-1.771652,"eighty":-1.310898,"marketCap":19015819},{"date":"2020-09-04","current":-1.699692,"twenty":-2.378727,"median":-1.77812,"eighty":-1.312886,"marketCap":16656192},{"date":"2020-09-11","current":-1.770513,"twenty":-2.378727,"median":-1.77812,"eighty":-1.313788,"marketCap":17350200},{"date":"2020-09-18","current":-1.79412,"twenty":-2.378727,"median":-1.784078,"eighty":-1.316152,"marketCap":17581536},{"date":"2020-09-25","current":-1.83189,"twenty":-2.375929,"median":-1.784078,"eighty":-1.317909,"marketCap":17951673},{"date":"2020-10-02","current":-1.803562,"twenty":-2.371265,"median":-1.784677,"eighty":-1.318626,"marketCap":17674070},{"date":"2020-10-09","current":-1.813005,"twenty":-2.366601,"median":-1.787082,"eighty":-1.319821,"marketCap":17766604},{"date":"2020-10-16","current":-1.770513,"twenty":-2.364735,"median":-1.786045,"eighty":-1.320781,"marketCap":17350200},{"date":"2020-10-23","current":-1.803562,"twenty":-2.364735,"median":-1.789398,"eighty":-1.323134,"marketCap":17674070},{"date":"2020-10-30","current":-1.661921,"twenty":-2.364151,"median":-1.78824,"eighty":-1.326571,"marketCap":16286054},{"date":"2020-11-06","current":-1.558051,"twenty":-2.361547,"median":-1.784677,"eighty":-1.329766,"marketCap":15268176},{"date":"2020-11-13","current":-1.910768,"twenty":-2.357272,"median":-1.788178,"eighty":-1.331611,"marketCap":16008451},{"date":"2020-11-20","current":-1.844498,"twenty":-2.354295,"median":-1.791759,"eighty":-1.332022,"marketCap":15453244},{"date":"2020-11-27","current":-1.841682,"twenty":-2.352429,"median":-1.79412,"eighty":-1.332406,"marketCap":15429648},{"date":"2020-12-04","current":-2.093008,"twenty":-2.350742,"median":-1.794485,"eighty":-1.333498,"marketCap":17535268},{"date":"2020-12-11","current":-2.010172,"twenty":-2.350742,"median":-1.795334,"eighty":-1.335478,"marketCap":16841260},{"date":"2020-12-18","current":-1.971515,"twenty":-2.349259,"median":-1.800928,"eighty":-1.339583,"marketCap":16517390},{"date":"2020-12-24","current":-3.907231,"twenty":-2.352992,"median":-1.803562,"eighty":-1.343088,"marketCap":32734864},{"date":"2020-12-31","current":-3.24287,"twenty":-2.363762,"median":-1.803562,"eighty":-1.343337,"marketCap":27168835},{"date":"2021-01-08","current":-3.453361,"twenty":-2.369399,"median":-1.812822,"eighty":-1.349968,"marketCap":28932330},{"date":"2021-01-15","current":-5.236518,"twenty":-2.378727,"median":-1.813098,"eighty":-1.353549,"marketCap":43871660},{"date":"2021-01-22","current":-5.614758,"twenty":-2.383391,"median":-1.815465,"eighty":-1.355611,"marketCap":47040560},{"date":"2021-01-29","current":-5.303761,"twenty":-2.406712,"median":-1.817726,"eighty":-1.359794,"marketCap":44435020},{"date":"2021-02-05","current":-5.959376,"twenty":-2.421618,"median":-1.818696,"eighty":-1.360711,"marketCap":49927780},{"date":"2021-02-12","current":-5.858512,"twenty":-2.430327,"median":-1.822448,"eighty":-1.360886,"marketCap":49082740},{"date":"2021-02-19","current":-6.001403,"twenty":-2.45182,"median":-1.823527,"eighty":-1.360959,"marketCap":50279880},{"date":"2021-02-26","current":-4.656551,"twenty":-2.478185,"median":-1.828143,"eighty":-1.360979,"marketCap":39012680},{"date":"2021-03-05","current":-4.538876,"twenty":-2.531229,"median":-1.83189,"eighty":-1.361518,"marketCap":38026800},{"date":"2021-03-12","current":-4.749009,"twenty":-2.623327,"median":-1.83444,"eighty":-1.362381,"marketCap":39787300},{"date":"2021-03-19","current":-4.757415,"twenty":-2.813834,"median":-1.836612,"eighty":-1.363662,"marketCap":39857720},{"date":"2021-03-26","current":-5.327209,"twenty":-3.152581,"median":-1.837114,"eighty":-1.365128,"marketCap":36554082},{"date":"2021-04-01","current":-5.296176,"twenty":-3.229714,"median":-1.841508,"eighty":-1.366329,"marketCap":36341145},{"date":"2021-04-09","current":-4.778972,"twenty":-3.295628,"median":-1.846055,"eighty":-1.367317,"marketCap":32792205},{"date":"2021-04-16","current":-4.458305,"twenty":-3.335397,"median":-1.84966,"eighty":-1.367514,"marketCap":30591862},{"date":"2021-04-23","current":-4.582434,"twenty":-3.387553,"median":-1.850209,"eighty":-1.36781,"marketCap":31443608},{"date":"2021-04-30","current":-4.375552,"twenty":-3.436211,"median":-1.85327,"eighty":-1.368365,"marketCap":30024032},{"date":"2021-05-07","current":-4.065229,"twenty":-3.507934,"median":-1.855442,"eighty":-1.36955,"marketCap":27894668},{"date":"2021-05-14","current":-3.84629,"twenty":-3.592237,"median":-1.856658,"eighty":-1.370579,"marketCap":26617050},{"date":"2021-05-21","current":-4.457081,"twenty":-3.624693,"median":-1.860966,"eighty":-1.372976,"marketCap":30843837},{"date":"2021-05-28","current":-4.502723,"twenty":-3.657462,"median":-1.862026,"eighty":-1.376507,"marketCap":31159693},{"date":"2021-06-04","current":-4.492467,"twenty":-3.695087,"median":-1.864321,"eighty":-1.378682,"marketCap":31088714},{"date":"2021-06-11","current":-4.605291,"twenty":-3.722618,"median":-1.866588,"eighty":-1.383416,"marketCap":31869481},{"date":"2021-06-18","current":-4.646318,"twenty":-3.770462,"median":-1.870969,"eighty":-1.384179,"marketCap":32153396},{"date":"2021-06-25","current":-4.48221,"twenty":-3.837699,"median":-1.875811,"eighty":-1.385038,"marketCap":31017735},{"date":"2021-07-02","current":-3.723209,"twenty":-3.839047,"median":-1.876394,"eighty":-1.386577,"marketCap":25765304},{"date":"2021-07-09","current":-3.712952,"twenty":-3.836033,"median":-1.876592,"eighty":-1.389358,"marketCap":25694325},{"date":"2021-07-16","current":-3.353965,"twenty":-3.829294,"median":-1.88011,"eighty":-1.389483,"marketCap":23210067},{"date":"2021-07-23","current":-3.384735,"twenty":-3.813931,"median":-1.883246,"eighty":-1.389936,"marketCap":23423004},{"date":"2021-07-30","current":-2.584707,"twenty":-3.813931,"median":-1.883825,"eighty":-1.389936,"marketCap":17886657},{"date":"2021-08-06","current":-2.297517,"twenty":-3.807412,"median":-1.888823,"eighty":-1.389936,"marketCap":15899251},{"date":"2021-08-13","current":-2.655447,"twenty":-3.805263,"median":-1.896043,"eighty":-1.391094,"marketCap":20569361},{"date":"2021-08-20","current":-2.476245,"twenty":-3.784749,"median":-1.89809,"eighty":-1.393654,"marketCap":19181244},{"date":"2021-08-27","current":-2.736902,"twenty":-3.784749,"median":-1.899982,"eighty":-1.395466,"marketCap":21200323},{"date":"2021-09-03","current":-2.85094,"twenty":-3.771513,"median":-1.911284,"eighty":-1.395466,"marketCap":22083670},{"date":"2021-09-10","current":-2.655447,"twenty":-3.767311,"median":-1.912049,"eighty":-1.396139,"marketCap":20569361},{"date":"2021-09-17","current":-3.258217,"twenty":-3.758005,"median":-1.914898,"eighty":-1.39729,"marketCap":25238480},{"date":"2021-09-24","current":-3.111597,"twenty":-3.746166,"median":-1.916232,"eighty":-1.398455,"marketCap":24102748},{"date":"2021-10-01","current":-3.290799,"twenty":-3.73654,"median":-1.921239,"eighty":-1.400026,"marketCap":25490864},{"date":"2021-10-08","current":-3.013851,"twenty":-3.733721,"median":-1.921812,"eighty":-1.400725,"marketCap":23345594},{"date":"2021-10-15","current":-3.16047,"twenty":-3.726083,"median":-1.934833,"eighty":-1.404026,"marketCap":24481325},{"date":"2021-10-22","current":-3.030142,"twenty":-3.723415,"median":-1.938122,"eighty":-1.406814,"marketCap":23471786},{"date":"2021-10-29","current":-3.103587,"twenty":-3.717552,"median":-1.942952,"eighty":-1.40731,"marketCap":24040700},{"date":"2021-11-05","current":-3.18526,"twenty":-3.713589,"median":-1.945331,"eighty":-1.411034,"marketCap":24673350},{"date":"2021-11-12","current":-2.417531,"twenty":-3.70885,"median":-1.949271,"eighty":-1.414727,"marketCap":18726440},{"date":"2021-11-19","current":-2.004514,"twenty":-3.704044,"median":-1.953616,"eighty":-1.416372,"marketCap":17587725},{"date":"2021-11-26","current":-2.148724,"twenty":-3.703099,"median":-1.958204,"eighty":-1.416739,"marketCap":18853029},{"date":"2021-12-03","current":-1.802621,"twenty":-3.700024,"median":-1.964089,"eighty":-1.417068,"marketCap":15816300},{"date":"2021-12-10","current":-2.018935,"twenty":-3.689314,"median":-1.96267,"eighty":-1.417432,"marketCap":17714256},{"date":"2021-12-17","current":-1.301348,"twenty":-3.675717,"median":-1.953896,"eighty":-1.416739,"marketCap":11418103},{"date":"2021-12-23","current":-1.251884,"twenty":-3.668498,"median":-1.949271,"eighty":-1.409172,"marketCap":10984104},{"date":"2021-12-31","current":-2.177566,"twenty":-3.662281,"median":-1.949271,"eighty":-1.405821,"marketCap":19106090},{"date":"2022-01-07","current":-1.442097,"twenty":-3.657462,"median":-1.946831,"eighty":-1.40731,"marketCap":12653040},{"date":"2022-01-14","current":-1.254624,"twenty":-3.656858,"median":-1.945081,"eighty":-1.399355,"marketCap":11008144},{"date":"2022-01-21","current":-0.995191,"twenty":-3.655043,"median":-1.941878,"eighty":-1.395634,"marketCap":8731862},{"date":"2022-01-28","current":-1.03831,"twenty":-3.646102,"median":-1.935761,"eighty":-1.390168,"marketCap":9110188},{"date":"2022-02-04","current":-0.952505,"twenty":-3.624865,"median":-1.934238,"eighty":-1.389383,"marketCap":8357332},{"date":"2022-02-11","current":-1.027638,"twenty":-3.624779,"median":-1.921812,"eighty":-1.384179,"marketCap":9016556},{"date":"2022-02-18","current":-0.961302,"twenty":-3.624435,"median":-1.919614,"eighty":-1.372027,"marketCap":8434516},{"date":"2022-02-25","current":-0.850981,"twenty":-3.624435,"median":-1.916554,"eighty":-1.367883,"marketCap":7466558},{"date":"2022-03-04","current":-0.842184,"twenty":-3.623756,"median":-1.915022,"eighty":-1.365685,"marketCap":7389375},{"date":"2022-03-11","current":-0.826754,"twenty":-3.598787,"median":-1.91353,"eighty":-1.360979,"marketCap":7253987},{"date":"2022-03-18","current":-1.047251,"twenty":-3.582412,"median":-1.911799,"eighty":-1.360711,"marketCap":9188637},{"date":"2022-03-25","current":-0.895542,"twenty":-3.579614,"median":-1.901482,"eighty":-1.347928,"marketCap":7857537},{"date":"2022-04-01","current":-0.901599,"twenty":-3.579614,"median":-1.899654,"eighty":-1.334272,"marketCap":7910680},{"date":"2022-04-08","current":-0.905725,"twenty":-3.579228,"median":-1.896089,"eighty":-1.330995,"marketCap":7946880},{"date":"2022-04-14","current":-0.858047,"twenty":-3.53851,"median":-1.892422,"eighty":-1.323048,"marketCap":7528558},{"date":"2022-04-22","current":-0.494302,"twenty":-3.521169,"median":-1.885176,"eighty":-1.318052,"marketCap":6806878},{"date":"2022-04-29","current":-0.487405,"twenty":-3.513925,"median":-1.883727,"eighty":-1.310898,"marketCap":6711898},{"date":"2022-05-06","current":-0.413926,"twenty":-3.503307,"median":-1.882533,"eighty":-1.301112,"marketCap":5700048},{"date":"2022-05-13","current":-0.411535,"twenty":-3.490041,"median":-1.878351,"eighty":-1.29027,"marketCap":5667122},{"date":"2022-05-20","current":-0.351851,"twenty":-3.482609,"median":-1.876586,"eighty":-1.285679,"marketCap":4845231},{"date":"2022-05-27","current":-0.367853,"twenty":-3.458976,"median":-1.876006,"eighty":-1.279982,"marketCap":5065584},{"date":"2022-06-03","current":-0.367853,"twenty":-3.449313,"median":-1.874951,"eighty":-1.270404,"marketCap":5065584},{"date":"2022-06-10","current":-0.377141,"twenty":-3.444037,"median":-1.866588,"eighty":-1.267689,"marketCap":5193489},{"date":"2022-06-17","current":-0.358564,"twenty":-3.433157,"median":-1.865098,"eighty":-1.257405,"marketCap":4937678},{"date":"2022-06-24","current":-0.365646,"twenty":-3.424681,"median":-1.862864,"eighty":-1.254624,"marketCap":5035190},{"date":"2022-07-01","current":-0.413834,"twenty":-3.412972,"median":-1.862026,"eighty":-1.250577,"marketCap":5698782},{"date":"2022-07-08","current":-0.38797,"twenty":-3.399927,"median":-1.860305,"eighty":-1.246669,"marketCap":5945667},{"date":"2022-07-15","current":-0.226472,"twenty":-3.396343,"median":-1.856658,"eighty":-1.242383,"marketCap":3470701},{"date":"2022-07-22","current":-0.126197,"twenty":-3.394026,"median":-1.855442,"eighty":-1.235587,"marketCap":1933975},{"date":"2022-07-29","current":-0.352876,"twenty":-3.389838,"median":-1.85327,"eighty":-1.216788,"marketCap":5407854},{"date":"2022-08-05","current":-0.361032,"twenty":-3.387783,"median":-1.850209,"eighty":-1.210617,"marketCap":5532849},{"date":"2022-08-12","current":-0.39347,"twenty":-3.384516,"median":-1.84966,"eighty":-1.200587,"marketCap":5974007},{"date":"2022-08-19","current":-0.321071,"twenty":-3.383642,"median":-1.846055,"eighty":-1.196009,"marketCap":4874789},{"date":"2022-08-26","current":-0.52955,"twenty":-3.378106,"median":-1.841508,"eighty":-1.189389,"marketCap":8040094},{"date":"2022-09-02","current":-0.520591,"twenty":-3.355709,"median":-1.837114,"eighty":-1.177355,"marketCap":7904070},{"date":"2022-09-09","current":-0.450372,"twenty":-3.354693,"median":-1.836612,"eighty":-1.171777,"marketCap":6837940},{"date":"2022-09-16","current":-0.593232,"twenty":-3.353965,"median":-1.83444,"eighty":-1.154819,"marketCap":9006964},{"date":"2022-09-23","current":-0.481849,"twenty":-3.353965,"median":-1.83189,"eighty":-1.138733,"marketCap":7315860},{"date":"2022-09-30","current":-0.372283,"twenty":-3.338005,"median":-1.831463,"eighty":-1.119409,"marketCap":5652329},{"date":"2022-10-07","current":-0.469743,"twenty":-3.331485,"median":-1.827931,"eighty":-1.110414,"marketCap":7132045},{"date":"2022-10-14","current":-0.372888,"twenty":-3.323381,"median":-1.82346,"eighty":-1.103925,"marketCap":5661520},{"date":"2022-10-21","current":-0.410419,"twenty":-3.323381,"median":-1.822408,"eighty":-1.083198,"marketCap":6231348},{"date":"2022-10-28","current":-0.383179,"twenty":-3.315937,"median":-1.817843,"eighty":-1.059941,"marketCap":5817763},{"date":"2022-11-04","current":-0.353518,"twenty":-3.308649,"median":-1.816886,"eighty":-1.03831,"marketCap":5367415},{"date":"2022-11-11","current":-0.40735,"twenty":-3.308649,"median":-1.813667,"eighty":-1.029485,"marketCap":7033876},{"date":"2022-11-18","current":-0.253271,"twenty":-3.302147,"median":-1.813005,"eighty":-1.023889,"marketCap":4373335},{"date":"2022-11-25","current":-0.246659,"twenty":-3.294369,"median":-1.807688,"eighty":-1.002752,"marketCap":4259148},{"date":"2022-12-02","current":-0.249965,"twenty":-3.291124,"median":-1.803562,"eighty":-0.99372,"marketCap":4316242},{"date":"2022-12-09","current":-0.210288,"twenty":-3.286839,"median":-1.802621,"eighty":-0.98077,"marketCap":3631124},{"date":"2022-12-16","current":-0.201691,"twenty":-3.280633,"median":-1.799477,"eighty":-0.959543,"marketCap":3482682},{"date":"2022-12-23","current":-0.254894,"twenty":-3.262439,"median":-1.794796,"eighty":-0.927095,"marketCap":4401356},{"date":"2022-12-30","current":-0.356852,"twenty":-3.255237,"median":-1.79432,"eighty":-0.919567,"marketCap":6161898},{"date":"2023-01-06","current":-0.384942,"twenty":-3.255237,"median":-1.79432,"eighty":-0.901483,"marketCap":6646946},{"date":"2023-01-13","current":-0.383902,"twenty":-3.255237,"median":-1.79432,"eighty":-0.890151,"marketCap":6628981},{"date":"2023-01-20","current":-0.383902,"twenty":-3.255237,"median":-1.79432,"eighty":-0.868049,"marketCap":6628981},{"date":"2023-01-27","current":-0.371417,"twenty":-3.255237,"median":-1.79432,"eighty":-0.847463,"marketCap":6413405},{"date":"2023-02-03","current":-0.37912,"twenty":-3.255237,"median":-1.79432,"eighty":-0.836238,"marketCap":6546415},{"date":"2023-02-10","current":-0.66828,"twenty":-3.255237,"median":-1.79432,"eighty":-0.833957,"marketCap":11539444},{"date":"2023-02-17","current":-0.678989,"twenty":-3.255237,"median":-1.79432,"eighty":-0.830302,"marketCap":11724371},{"date":"2023-02-24","current":-0.551545,"twenty":-3.255237,"median":-1.79432,"eighty":-0.830302,"marketCap":9523740},{"date":"2023-03-03","current":-0.410178,"twenty":-3.255237,"median":-1.79432,"eighty":-0.830302,"marketCap":7082704},{"date":"2023-03-10","current":-0.403752,"twenty":-3.255237,"median":-1.79432,"eighty":-0.830302,"marketCap":6971747},{"date":"2023-03-17","current":-0.363056,"twenty":-3.255237,"median":-1.79432,"eighty":-0.828312,"marketCap":6269025},{"date":"2023-03-24","current":-0.469093,"twenty":-3.255237,"median":-1.79432,"eighty":-0.828312,"marketCap":6371976},{"date":"2023-03-31","current":-0.471919,"twenty":-3.254244,"median":-1.79422,"eighty":-0.822312,"marketCap":6410361},{"date":"2023-04-06","current":-0.470506,"twenty":-3.254244,"median":-1.79422,"eighty":-0.822312,"marketCap":6391169},{"date":"2023-04-14","current":-0.593431,"twenty":-3.255237,"median":-1.79432,"eighty":-0.817871,"marketCap":8060934},{"date":"2023-04-21","current":-0.497352,"twenty":-3.255237,"median":-1.79432,"eighty":-0.674705,"marketCap":6755830},{"date":"2023-04-28","current":-0.673968,"twenty":-3.255237,"median":-1.79432,"eighty":-0.629004,"marketCap":9154917},{"date":"2023-05-05","current":-0.441108,"twenty":-3.255237,"median":-1.79432,"eighty":-0.593184,"marketCap":5991839},{"date":"2023-05-12","current":-0.430836,"twenty":-3.255237,"median":-1.79432,"eighty":-0.582389,"marketCap":5121403},{"date":"2023-05-19","current":-0.354205,"twenty":-3.255237,"median":-1.789398,"eighty":-0.565864,"marketCap":4210481},{"date":"2023-05-26","current":-0.348245,"twenty":-3.255237,"median":-1.784677,"eighty":-0.543928,"marketCap":4139632},{"date":"2023-06-02","current":-0.283534,"twenty":-3.255237,"median":-1.778483,"eighty":-0.536165,"marketCap":3370409},{"date":"2023-06-09","current":-0.432066,"twenty":-3.255237,"median":-1.773779,"eighty":-0.519088,"marketCap":5136029},{"date":"2023-06-16","current":-0.426732,"twenty":-3.255237,"median":-1.767229,"eighty":-0.507649,"marketCap":5072621},{"date":"2023-06-23","current":-0.384006,"twenty":-3.256231,"median":-1.760515,"eighty":-0.498173,"marketCap":4564725},{"date":"2023-06-30","current":-0.356855,"twenty":-3.257224,"median":-1.758939,"eighty":-0.487981,"marketCap":4241979},{"date":"2023-07-07","current":-0.34672,"twenty":-3.257224,"median":-1.758246,"eighty":-0.484271,"marketCap":4121505},{"date":"2023-07-14","current":-0.375269,"twenty":-3.257224,"median":-1.747257,"eighty":-0.478858,"marketCap":4460869},{"date":"2023-07-21","current":-0.368002,"twenty":-3.258217,"median":-1.731372,"eighty":-0.471919,"marketCap":4374485},{"date":"2023-07-28","current":-0.343003,"twenty":-3.258217,"median":-1.719851,"eighty":-0.470506,"marketCap":4077324},{"date":"2023-08-04","current":-0.333353,"twenty":-3.258217,"median":-1.708889,"eighty":-0.467321,"marketCap":3962606},{"date":"2023-08-11","current":-0.321023,"twenty":-3.258217,"median":-1.701755,"eighty":-0.460057,"marketCap":3884418},{"date":"2023-08-18","current":-0.323718,"twenty":-3.258217,"median":-1.687036,"eighty":-0.450372,"marketCap":3917030},{"date":"2023-08-25","current":-0.31144,"twenty":-3.258217,"median":-1.677015,"eighty":-0.441108,"marketCap":3768466},{"date":"2023-09-01","current":-0.298204,"twenty":-3.258217,"median":-1.651592,"eighty":-0.433422,"marketCap":3608306},{"date":"2023-09-08","current":-0.299462,"twenty":-3.258217,"median":-1.649312,"eighty":-0.431597,"marketCap":3623525},{"date":"2023-09-15","current":-0.317429,"twenty":-3.258217,"median":-1.649312,"eighty":-0.423737,"marketCap":3840936},{"date":"2023-09-22","current":-0.33905,"twenty":-3.258217,"median":-1.649312,"eighty":-0.417213,"marketCap":4102555},{"date":"2023-09-29","current":-0.324616,"twenty":-3.258217,"median":-1.649312,"eighty":-0.413926,"marketCap":3927901},{"date":"2023-10-06","current":-0.364744,"twenty":-3.262439,"median":-1.651448,"eighty":-0.411489,"marketCap":4413453},{"date":"2023-10-13","current":-0.374327,"twenty":-3.262439,"median":-1.651448,"eighty":-0.410178,"marketCap":4529406},{"date":"2023-10-20","current":-0.365223,"twenty":-3.262439,"median":-1.651448,"eighty":-0.406787,"marketCap":4419251},{"date":"2023-10-27","current":-0.351628,"twenty":-3.275107,"median":-1.656829,"eighty":-0.404826,"marketCap":4254743},{"date":"2023-11-03","current":-0.365283,"twenty":-3.275107,"median":-1.656829,"eighty":-0.402737,"marketCap":4419975},{"date":"2023-11-10","current":-0.388342,"twenty":-3.275107,"median":-1.656829,"eighty":-0.400256,"marketCap":4698987},{"date":"2023-11-17","current":-0.349354,"twenty":-3.275107,"median":-1.644405,"eighty":-0.395818,"marketCap":4452069},{"date":"2023-11-24","current":-0.331856,"twenty":-3.275107,"median":-1.626965,"eighty":-0.393306,"marketCap":4229082},{"date":"2023-12-01","current":-0.312125,"twenty":-3.275107,"median":-1.615241,"eighty":-0.390147,"marketCap":3977643},{"date":"2023-12-08","current":-0.325822,"twenty":-3.275107,"median":-1.604609,"eighty":-0.38877,"marketCap":4152189},{"date":"2023-12-15","current":-0.357197,"twenty":-3.275107,"median":-1.593476,"eighty":-0.385184,"marketCap":4552030},{"date":"2023-12-22","current":-0.324615,"twenty":-3.275107,"median":-1.558816,"eighty":-0.383923,"marketCap":4136811},{"date":"2023-12-29","current":-0.334665,"twenty":-3.279329,"median":-1.545915,"eighty":-0.382751,"marketCap":4264883},{"date":"2024-01-05","current":-0.334873,"twenty":-3.280633,"median":-1.530088,"eighty":-0.381786,"marketCap":4267528},{"date":"2024-01-12","current":-0.320271,"twenty":-3.280633,"median":-1.491286,"eighty":-0.378821,"marketCap":4081448},{"date":"2024-01-19","current":-0.325822,"twenty":-3.281937,"median":-1.476901,"eighty":-0.377028,"marketCap":4152189},{"date":"2024-01-26","current":-0.337889,"twenty":-3.280633,"median":-1.463814,"eighty":-0.37481,"marketCap":4305974},{"date":"2024-02-02","current":-0.512868,"twenty":-3.280633,"median":-1.448862,"eighty":-0.374019,"marketCap":6535854},{"date":"2024-02-09","current":-0.402209,"twenty":-3.280633,"median":-1.443526,"eighty":-0.374019,"marketCap":5125647},{"date":"2024-02-16","current":-0.381151,"twenty":-3.280633,"median":-1.432774,"eighty":-0.374019,"marketCap":4857292},{"date":"2024-02-23","current":-1.216404,"twenty":-3.280633,"median":-1.421426,"eighty":-0.372932,"marketCap":15501532},{"date":"2024-03-01","current":-1.362616,"twenty":-3.279329,"median":-1.417635,"eighty":-0.372937,"marketCap":17364822},{"date":"2024-03-08","current":-1.352463,"twenty":-3.279329,"median":-1.415418,"eighty":-0.372937,"marketCap":17235427},{"date":"2024-03-15","current":-1.267172,"twenty":-3.279329,"median":-1.400361,"eighty":-0.372937,"marketCap":16148508},{"date":"2024-03-22","current":-1.184522,"twenty":-3.279329,"median":-1.395466,"eighty":-0.372937,"marketCap":15095232},{"date":"2024-03-28","current":-1.294777,"twenty":-3.279329,"median":-1.389936,"eighty":-0.372937,"marketCap":16202699},{"date":"2024-04-05","current":-1.219033,"twenty":-3.280633,"median":-1.389936,"eighty":-0.372932,"marketCap":15254850},{"date":"2024-04-12","current":-1.265192,"twenty":-3.280633,"median":-1.384173,"eighty":-0.372932,"marketCap":15832486},{"date":"2024-04-19","current":-1.070063,"twenty":-3.280633,"median":-1.384173,"eighty":-0.372932,"marketCap":13390660},{"date":"2024-04-26","current":-1.007118,"twenty":-3.279329,"median":-1.382924,"eighty":-0.372937,"marketCap":12602974},{"date":"2024-05-03","current":-1.138463,"twenty":-3.279329,"median":-1.382924,"eighty":-0.372937,"marketCap":14246612},{"date":"2024-05-10","current":-1.018239,"twenty":-3.279329,"median":-1.371079,"eighty":-0.372937,"marketCap":12742132},{"date":"2024-05-17","current":5.43761,"twenty":-3.279329,"median":-1.36735,"eighty":-0.372283,"marketCap":15267978},{"date":"2024-05-24","current":4.982216,"twenty":-3.279329,"median":-1.360979,"eighty":-0.371392,"marketCap":13989301},{"date":"2024-05-31","current":4.638099,"twenty":-3.279329,"median":-1.360979,"eighty":-0.369336,"marketCap":13023073},{"date":"2024-06-07","current":4.039635,"twenty":-3.279329,"median":-1.343026,"eighty":-0.367853,"marketCap":11342677},{"date":"2024-06-14","current":5.120489,"twenty":-3.280633,"median":-1.325317,"eighty":-0.366919,"marketCap":14377549},{"date":"2024-06-21","current":4.157752,"twenty":-3.281937,"median":-1.303928,"eighty":-0.36547,"marketCap":11674332},{"date":"2024-06-28","current":4.390502,"twenty":-3.285849,"median":-1.299002,"eighty":-0.365223,"marketCap":12327857},{"date":"2024-07-05","current":4.570353,"twenty":-3.285849,"median":-1.289286,"eighty":-0.363094,"marketCap":12832853},{"date":"2024-07-12","current":4.475138,"twenty":-3.285849,"median":-1.27947,"eighty":-0.362232,"marketCap":12565502},{"date":"2024-07-15","current":4.475138,"twenty":-3.285849,"median":-1.278611,"eighty":-0.361869,"marketCap":12565502},{"date":"2024-08-02","current":4.792524,"twenty":-3.298258,"median":-1.269045,"eighty":-0.361021,"marketCap":13456673},{"date":"2024-08-09","current":3.448924,"twenty":-3.298258,"median":-1.269045,"eighty":-0.359495,"marketCap":9684051},{"date":"2024-08-16","current":3.016946,"twenty":-3.298258,"median":-1.258898,"eighty":-0.358977,"marketCap":9654271},{"date":"2024-08-23","current":3.434677,"twenty":-3.298258,"median":-1.254624,"eighty":-0.357598,"marketCap":10991016},{"date":"2024-08-30","current":3.444053,"twenty":-3.298258,"median":-1.251884,"eighty":-0.356718,"marketCap":11021019},{"date":"2024-09-06","current":3.267585,"twenty":-3.298258,"median":-1.247987,"eighty":-0.355819,"marketCap":10456318},{"date":"2024-09-13","current":3.360414,"twenty":-3.298258,"median":-1.236193,"eighty":-0.354257,"marketCap":10753372},{"date":"2024-09-20","current":3.451387,"twenty":-3.298258,"median":-1.218435,"eighty":-0.353426,"marketCap":11044486},{"date":"2024-09-27","current":3.202605,"twenty":-3.298258,"median":-1.197315,"eighty":-0.352722,"marketCap":10248380},{"date":"2024-10-04","current":3.239736,"twenty":-3.298258,"median":-1.15357,"eighty":-0.351775,"marketCap":10367202},{"date":"2024-10-11","current":3.026229,"twenty":-3.298258,"median":-1.110414,"eighty":-0.351292,"marketCap":9683976},{"date":"2024-10-18","current":3.072644,"twenty":-3.298258,"median":-1.076987,"eighty":-0.348689,"marketCap":9832503},{"date":"2024-10-25","current":3.360321,"twenty":-3.298258,"median":-1.059941,"eighty":-0.347114,"marketCap":10753075},{"date":"2024-10-31","current":3.434677,"twenty":-3.298258,"median":-1.047251,"eighty":-0.346583,"marketCap":10991016},{"date":"2024-11-08","current":3.312329,"twenty":-3.300202,"median":-1.028183,"eighty":-0.343072,"marketCap":10599498},{"date":"2024-11-15","current":1.818256,"twenty":-3.300202,"median":-1.017924,"eighty":-0.339665,"marketCap":10090644},{"date":"2024-11-22","current":1.789779,"twenty":-3.300202,"median":-1.00375,"eighty":-0.337901,"marketCap":9932608},{"date":"2024-11-29","current":1.762743,"twenty":-3.275107,"median":-0.991514,"eighty":-0.337259,"marketCap":9782568},{"date":"2024-12-06","current":1.884945,"twenty":-3.242681,"median":-0.97392,"eighty":-0.335032,"marketCap":10460746},{"date":"2024-12-13","current":1.899004,"twenty":-3.207693,"median":-0.932315,"eighty":-0.333314,"marketCap":10538767},{"date":"2024-12-20","current":1.751388,"twenty":-3.176761,"median":-0.912775,"eighty":-0.331759,"marketCap":9719552},{"date":"2024-12-27","current":1.811407,"twenty":-3.150909,"median":-0.900589,"eighty":-0.330504,"marketCap":10052639},{"date":"2025-01-03","current":1.935773,"twenty":-3.111597,"median":-0.884077,"eighty":-0.329408,"marketCap":10742821},{"date":"2025-01-10","current":2.014555,"twenty":-3.087252,"median":-0.854875,"eighty":-0.328778,"marketCap":11180035},{"date":"2025-01-17","current":1.892515,"twenty":-3.013851,"median":-0.839877,"eighty":-0.326848,"marketCap":10502758},{"date":"2025-01-24","current":2.054731,"twenty":-2.974464,"median":-0.826754,"eighty":-0.325822,"marketCap":11402994},{"date":"2025-01-31","current":2.157467,"twenty":-2.933793,"median":-0.678989,"eighty":-0.325219,"marketCap":11973144},{"date":"2025-02-07","current":1.995252,"twenty":-2.899813,"median":-0.658641,"eighty":-0.323418,"marketCap":11072907},{"date":"2025-02-14","current":1.946587,"twenty":-2.769484,"median":-0.593232,"eighty":-0.322805,"marketCap":10802836},{"date":"2025-02-21","current":1.897922,"twenty":-2.736902,"median":-0.586606,"eighty":-0.320271,"marketCap":10532765},{"date":"2025-02-28","current":1.81357,"twenty":-2.671738,"median":-0.572237,"eighty":-0.319226,"marketCap":10064642},{"date":"2025-03-07","current":1.784372,"twenty":-2.626123,"median":-0.547802,"eighty":-0.315365,"marketCap":9902600},{"date":"2025-03-14","current":1.757336,"twenty":-2.547925,"median":-0.535978,"eighty":-0.310841,"marketCap":9752561},{"date":"2025-03-21","current":1.719539,"twenty":-2.547925,"median":-0.518712,"eighty":-0.301447,"marketCap":9542805},{"date":"2025-03-28","current":2.521016,"twenty":-2.530404,"median":-0.50974,"eighty":-0.295484,"marketCap":9062379},{"date":"2025-04-04","current":2.364663,"twenty":-2.471908,"median":-0.498378,"eighty":-0.265771,"marketCap":8500332},{"date":"2025-04-11","current":2.167239,"twenty":-2.441112,"median":-0.487405,"eighty":-0.249965,"marketCap":7790645},{"date":"2025-04-17","current":2.295627,"twenty":-2.425369,"median":-0.484271,"eighty":-0.246363,"marketCap":8252167},{"date":"2025-04-25","current":2.671275,"twenty":-2.407586,"median":-0.479143,"eighty":-0.237401,"marketCap":9602521},{"date":"2025-05-02","current":2.74148,"twenty":-2.392272,"median":-0.471919,"eighty":-0.232433,"marketCap":9854887},{"date":"2025-05-09","current":2.604493,"twenty":-2.378727,"median":-0.470125,"eighty":-0.226277,"marketCap":9362458},{"date":"2025-05-16","current":-0.79055,"twenty":-2.378727,"median":-0.470125,"eighty":-0.226277,"marketCap":9527272},{"date":"2025-05-23","current":-0.775597,"twenty":-2.370332,"median":-0.470125,"eighty":-0.226277,"marketCap":9347076},{"date":"2025-05-30","current":-0.757715,"twenty":-2.361003,"median":-0.470125,"eighty":-0.226277,"marketCap":9131571},{"date":"2025-06-06","current":-0.780447,"twenty":-2.351675,"median":-0.470125,"eighty":-0.226277,"marketCap":9405518}],"updateTime":1749432770134}}}